Published in Adv Pharmacol on January 01, 2013
Polygonum cuspidatum and its active components inhibit replication of the influenza virus through toll-like receptor 9-induced interferon beta expression. PLoS One (2015) 1.41
At the centre: influenza A virus ribonucleoproteins. Nat Rev Microbiol (2014) 1.33
Quantitative influenza follow-up testing (QIFT)--a novel biomarker for the monitoring of disease activity at the point-of-care. PLoS One (2014) 0.83
Virus-host interactomics: new insights and opportunities for antiviral drug discovery. Genome Med (2014) 0.81
Investigation of the salicylaldehyde thiosemicarbazone scaffold for inhibition of influenza virus PA endonuclease. J Biol Inorg Chem (2015) 0.80
Detection of Rare Drug Resistance Mutations by Digital PCR in a Human Influenza A Virus Model System and Clinical Samples. J Clin Microbiol (2015) 0.78
N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes. Sci Rep (2016) 0.78
Potential of acylated peptides to target the influenza A virus. Beilstein J Org Chem (2015) 0.78
A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In Vitro. Antimicrob Agents Chemother (2016) 0.77
Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice. PLoS One (2014) 0.76
Parallel evolution of influenza across multiple spatiotemporal scales. Elife (2017) 0.75
Anti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus Binding. PLoS One (2016) 0.75
FPR2: A Novel Promising Target for the Treatment of Influenza. Front Microbiol (2017) 0.75
Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A (2004) 12.39
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis (2013) 7.83
Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet (2004) 7.52
Aetiology: Koch's postulates fulfilled for SARS virus. Nature (2003) 7.51
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52
Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog (2007) 6.04
Avian H5N1 influenza in cats. Science (2004) 5.40
Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe. Emerg Infect Dis (2005) 2.90
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial. AIDS (2002) 2.28
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial. Ann Intern Med (2003) 2.20
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus. Gastroenterology (2010) 1.98
Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med (2013) 1.95
Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests. J Clin Microbiol (2008) 1.85
Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy. J Hepatol (2008) 1.71
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b. Gastroenterology (2008) 1.56
Another phocine distemper outbreak in Europe. Science (2002) 1.55
Low nevirapine plasma concentrations predict virological failure in an unselected HIV-1-infected population. Clin Pharmacokinet (2003) 1.43
Fatal oseltamivir-resistant influenza virus infection. N Engl J Med (2008) 1.39
Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA. J Clin Microbiol (2010) 1.37
Global task force for influenza. Nature (2005) 1.31
Quantitative real-time PCR on Lightcycler for the detection of human immunodeficiency virus type 2 (HIV-2). J Virol Methods (2004) 1.27
Human herpes simplex virus keratitis: the pathogenesis revisited. Ocul Immunol Inflamm (2004) 1.21
Feline friend or potential foe? Nature (2006) 1.16
The effect of primer-template mismatches on the detection and quantification of nucleic acids using the 5' nuclease assay. J Mol Diagn (2009) 1.16
Validation of self-swab for virologic confirmation of influenza virus infections in a community setting. J Infect Dis (2011) 1.15
Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients. AIDS (2003) 1.15
Predominance of rhinovirus in the nose of symptomatic and asymptomatic infants. Pediatr Allergy Immunol (2003) 1.14
H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis. PLoS Pathog (2012) 1.13
Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: concordance analysis and correlation with clinical outcome in heavily treated patients. J Infect Dis (2003) 1.13
Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). Clin Infect Dis (2013) 1.12
Multidrug resistant 2009 A/H1N1 influenza clinical isolate with a neuraminidase I223R mutation retains its virulence and transmissibility in ferrets. PLoS Pathog (2011) 1.09
Results of 2 years of treatment with protease-inhibitor--containing antiretroviral therapy in dutch children infected with human immunodeficiency virus type 1. Clin Infect Dis (2002) 1.07
Preparing the outbreak assistance laboratory network in the Netherlands for the detection of the influenza virus A(H1N1) variant. J Clin Virol (2009) 1.07
Emerging viral infections in a rapidly changing world. Curr Opin Biotechnol (2003) 1.05
Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets. PLoS Pathog (2013) 1.04
Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010. Antiviral Res (2011) 0.97
Comparison of the efficacy of early versus late viral proteins in vaccination against SIV. Vaccine (2002) 0.95
Antibody-mediated enhancement of human immunodeficiency virus type 1 infectivity is determined by the structure of gp120 and depends on modulation of the gp120-CCR5 interaction. J Virol (2002) 0.94
Fatal human rabies due to Duvenhage virus from a bat in Kenya: failure of treatment with coma-induction, ketamine, and antiviral drugs. PLoS Negl Trop Dis (2009) 0.94
RegaDB: community-driven data management and analysis for infectious diseases. Bioinformatics (2013) 0.93
The potential for multidrug-resistant influenza. Curr Opin Infect Dis (2011) 0.93
Influenza A and B virus attachment to respiratory tract in marine mammals. Emerg Infect Dis (2012) 0.92
Rodent-borne hemorrhagic fevers: under-recognized, widely spread and preventable - epidemiology, diagnostics and treatment. Crit Rev Microbiol (2012) 0.91
Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene. J Clin Microbiol (2007) 0.89
Pigs, poultry, and pandemic influenza: how zoonotic pathogens threaten human health. Adv Exp Med Biol (2011) 0.87
Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapy. Clin Infect Dis (2005) 0.86
Report of the third meeting on "influenza vaccines that induce broad spectrum and long-lasting immune responses", World Health Organization, Geneva, Switzerland, 3-4 December 2007. Vaccine (2008) 0.86
Avian influenza a virus in wild birds in highly urbanized areas. PLoS One (2012) 0.86
Long-term response rates of successful hepatitis B vaccination in HIV-infected patients. Vaccine (2012) 0.84
Adenovirus DNA positivity in nasopharyngeal aspirate preceding hematopoietic stem cell transplantation: a very strong risk factor for adenovirus DNAemia in pediatric patients. Clin Infect Dis (2009) 0.84
Reconstitution of naive T cells during antiretroviral treatment of HIV-infected adults is dependent on age. AIDS (2002) 0.84
Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations. J Mol Diagn (2013) 0.82
Low cost HIV-1 quantitative RT-PCR assay in resource-limited settings: improvement and implementation. J Virol Methods (2012) 0.81
Satisfying the need for rapid diagnosis of new variant influenza A H1N1. Expert Rev Mol Diagn (2010) 0.81
Multi-science decision support for HIV drug resistance treatment. Stud Health Technol Inform (2008) 0.81
Therapy failure resulting from superinfection by a drug-resistant HIV variant. Antivir Ther (2012) 0.81
The influenza virus: disease, diagnostics, and treatment. MLO Med Lab Obs (2013) 0.79
Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network. Antivir Ther (2013) 0.79
HIV-2-infected individuals with undetectable plasma viremia carry replication-competent virus in peripheral blood lymphocytes. J Acquir Immune Defic Syndr (2004) 0.79
Current research on respiratory viral infections: Fourth International Symposium. Antiviral Res (2002) 0.79
DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes. Vaccine (2002) 0.78
Performance of a nurse-led paediatric point of care service for respiratory syncytial virus testing in secondary care. J Infect (2010) 0.78
Key reports from the XV International HIV Drug Resistance Workshop 2006. Antivir Ther (2007) 0.77
Serologic survey for selected virus infections in polar bears at Svalbard. J Wildl Dis (2005) 0.77
Viral shedding and susceptibility to oseltamivir in hospitalized immunocompromised patients with influenza in the Influenza Resistance Information Study (IRIS). Antivir Ther (2015) 0.77
HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption. AIDS (2013) 0.76
HIV-2 encephalitis: case report and literature review. AIDS Patient Care STDS (2012) 0.76
Population genetic tests suggest that the epidemiologies of JCV and BKV are strikingly different. Infect Genet Evol (2009) 0.76
Virological failure and drug resistance during first line anti-retroviral treatment in Indonesia. J Med Virol (2013) 0.76
Experimental infection of highly pathogenic avian influenza virus H5N1 in black-headed gulls (Chroicocephalus ridibundus). Vet Res (2014) 0.75
Strengthening the diagnostic capacity to detect Bio Safety Level 3 organisms in unusual respiratory viral outbreaks. J Clin Virol (2009) 0.75
Left main coronary artery spasm: medical versus surgical management. J Cardiothorac Vasc Anesth (2006) 0.75
Discordance between HCV RNA assays for week 24 HCV RNA determination during pegylated interferon-α/ribavirin treatment for chronic hepatitis C. Antivir Ther (2011) 0.75
Complete clinical and virological remission of refractory HIV-related Kaposi's sarcoma with pegylated interferon alpha. AIDS (2007) 0.75
A 5-year study of adenoviruses causing conjunctivitis in Izmir, Turkey. J Med Virol (2014) 0.75
New Avian Hepadnavirus in Palaeognathous Bird, Germany. Emerg Infect Dis (2017) 0.75
[Combating the new influenza A (H1N1) virus. I. Overview of the relevant virological aspects]. Ned Tijdschr Geneeskd (2009) 0.75